BREAKING NEWS

BREAKING NEWS

Gates Foundation invests $40 million in UK immunotherapy company

Now Reading:

Gates Foundation invests $40 million in UK immunotherapy company

Text size Aa Aa

LONDON (Reuters) – The Bill & Melinda Gates Foundation is to invest up to $40 million (29.41 million pounds) in privately held British biotech company Immunocore to support its development of immunotherapies for infectious diseases. Oxford-based Immunocore has so far concentrated on developing its T-cell receptor medicines to fight cancer, where it has collaborations with Roche <ROG.S>, GlaxoSmithKline <GSK.L>, AstraZeneca <AZN.L> and Eli Lilly <LLY.N>. The tie-up with the Gates Foundation will extend the work into finding and developing new treatments for tuberculosis, HIV and other infectious diseases.

(Reporting by Ben Hirschler; Editing by Mark Potter)
euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.